Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Policy Paper

Research Type: Policy Paper

Sort 1 results by:

Filter Applied. Clear All

Latest Posts

April 29, 2026 Public Comment: Lozier Institute on NIH’s Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research Public Comment: Lozier Institute on NIH’s Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research April 14, 2026 Drug-induced Abortion After the First Trimester Drug-induced Abortion After the First Trimester April 10, 2026 Abortion Law in America Today: Confronting Infringements on Pro-life Laws Abortion Law in America Today: Confronting Infringements on Pro-life Laws
Reset All Filters
Maternal & Public Health

Medical and Social Risks Associated with Unmitigated Distribution of Mifepristone: A Primer

Chemical abortions, or “medication” abortions, have become a more prevalent method of abortion in recent years in the United States. In 2000, the Food and Drug Administration (FDA) approved the use of mifepristone, in conjunction with the drug misoprostol, as an abortion-inducing, two-drug process. By 2018, the Charlotte Lozier Institute estimates that 41% of U.S. abortions were chemically induced.

Abortion

New Abortion Trends in the United States: A First Look

Today Charlotte Lozier Institute (CLI), the research arm of the national pro-life group Susan B. Anthony List (SBA List), published a new report on emerging abortion trends in the United States. Ahead of the Centers for Disease Control and Prevention, as well as the Guttmacher Institute, CLI has the first analysis of trends revealed by the latest available state abortion reports from calendar year 2018

New Abortion Trends in the United States: A First Look
Maternal & Public Health

New Abortion Trends in the United States: A First Look

To allow for a preliminary view of the current state of abortion in the U.S., the Charlotte Lozier Institute (CLI) reviewed all available state reports for 2017 and 2018. As of July 2020, 38 states had released 2018 abortion statistics. CLI’s preliminary review of 2017 state abortion reporting, published in May 2019, suggested that the long-term decline in abortions in the United States may be slowing. This preliminary review of 2018 state data indicates that the decline may have been interrupted.

A Policy and Funding Evaluation Of Human Fetal Tissue Research
Life & the Law

A Policy and Funding Evaluation Of Human Fetal Tissue Research

Here we evaluate the actions and policy changes made by the Trump administration that have been taken since his term in office and analyze the current standing of federal funds used to support fetal tissue research.  First, we give a brief overview of how federal tax dollars are used to fund medical research in the U.S.

FDA’s Race to Defend Women From Dangerous Drugs
Life & the Law

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court.  In mid-July, Judge Theodore D. Chuang issued a preliminary injunction prohibiting the Food and Drug Administration (FDA) from enforcing certain health and safety practices that abortion providers are required to follow when prescribing the only FDA-approved abortion drug regimen.

The “No-Test Medication Abortion” Protocol: Experimenting with Women’s Health
Maternal & Public Health

The “No-Test Medication Abortion” Protocol: Experimenting with Women’s Health

A trend of mounting concern is occurring in abortion provision.  When elective induced abortion was legalized in the United States in 1973, one oft-cited motivation was to improve abortion’s safety, as it was frequently claimed that many women were injured and sometimes died from illegal abortions. Recently, abortion advocates have changed their strategy. Whereas once they claimed they wanted abortion to be “safe, legal and rare,” now they favor immediate access and convenience to abortion for all women experiencing unintended pregnancies, regardless of whether it might be more dangerous for a woman, or whether the law prohibits it. Thus, they have begun encouraging women to seek more dangerous, “self-managed” abortions.

Addendum to Hyde @ 40: Analyzing the Impact of the Hyde Amendment
Life & the Law

Addendum to Hyde @ 40: Analyzing the Impact of the Hyde Amendment

Addendum: Since the Charlotte Lozier Institute’s analysis of the Hyde Amendment was published in November of 2016, three states have changed how their Medicaid programs cover elective abortions.

Life & the Law

Six States and Their Radical Approaches to Abortion Law

In 2019, there was a flurry of activity around abortion laws at the state level on both sides of the abortion debate. While states such as Alabama, Louisiana, and Missouri passed life-affirming legislation, other states went a decidedly different direction in codifying Roe v. Wade into state law and some went even further than the landmark 1973 Supreme Court ruling.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image